Search - Prime Therapeutics
Navigate to
-
Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainuaâ„¢ (eplontersen) The United States (U.S.)...
-
Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...
-
Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Events -
publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...
-
13th annual report the preeminent source for medical benefit drug trend
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Managed Healthcare Executive
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...
-
publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...